Cargando…
Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action
BACKGROUND: Drug resistance is a cause of ovarian cancer recurrence and low overall survival rates. There is a need for more effective treatment approaches because the development of new drug is expensive and time consuming. Alternatively, the concept of ‘drug repurposing’ is promising. We focused o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922745/ https://www.ncbi.nlm.nih.gov/pubmed/24495391 http://dx.doi.org/10.1186/1471-2407-14-61 |